Organoid Science (CEO Jongman Yoo), a bio company specializing in organoids, announced that it will hold an ‘Organoid-based platform webinar to increase the success rate of new drug development’ online on October 29th at 2pm.
Organoid Science will hold this event in the form of a webinar (webinar (web + seminar)) to not only follow the government’s quarantine guidelines but also communicate in real time with overseas participants.
In this webinar, Kim Ji-hyo, head of the new drug development division, will give a lecture on the introduction and strategy of the company’s organoid-based evaluation model and introduce the use of organoids in the new drug development process and the need for a high clinical prediction model. Various events are also available for pre-registration and participants.
Introduction materials will be provided to all pre-registrants, and Starbucks gifticons will be given on a first-come, first-served basis just by participating in the survey conducted during the webinar live. As Organoid Science has already been recognized for its unrivaled technology in the field of organoid-based regenerative therapies, it is expected to prove the excellence of its new drug development evaluation platform through this event and become a growth engine leading the domestic and overseas organoid market.
Jongman Yoo, CEO of Organoid Science, expressed his expectations for this webinar, saying, “In new drug development, a high success rate and rapid decision-making are more important than anything else.” He added, “I hope I can inform many people of the solutions using Organoid Science’s unique technology.” indicated.
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2021’ news